Market Place
Sourcing Support
Interpace Biosciences Announces 2025 Revenue and 2026 Guidance
20 Jan 2026 //
GLOBENEWSWIRE
Interpace Biosciences Repays Debt Early To Broadoak Capital
03 Dec 2025 //
GLOBENEWSWIRE
Interpace Biosciences Reveals Q3 2025 Financial & Business Update
12 Nov 2025 //
GLOBENEWSWIRE
Interpace Biosciences Unveils Two Posters at 2025 ATA Meeting
15 Sep 2025 //
GLOBENEWSWIRE
Interpace Biosciences Unveils Q2 2025 Financial and Business
07 Aug 2025 //
GLOBENEWSWIRE
Interpace Biosciences Q1 2025 Financial and Business Results
08 May 2025 //
GLOBENEWSWIRE
Interpace Diagnostics to Stop Accepting PancraGEN Specimens May 2
24 Apr 2025 //
GLOBENEWSWIRE
Interpace Bio Announces Full-year & Q4 2024 Financial & Results
31 Jan 2025 //
GLOBENEWSWIRE
Interpace Diagnostics To End PancraGEN Offering On 02/07/2025
09 Jan 2025 //
GLOBENEWSWIRE
Interpace Bio Reports Record Q3 2024 Financial & Business Results
04 Nov 2024 //
GLOBENEWSWIRE
Interpace Biosciences Capital Restructuring Of Preferred Stock
15 Oct 2024 //
GLOBENEWSWIRE
Interpace Biosciences Reports Record Q2 2024 Results
01 Aug 2024 //
GLOBENEWSWIRE
Interpace Diagnostics Extends Medicare Coverage For PancraGEN® Test
29 Jul 2024 //
GLOBENEWSWIRE
Interpace: New Pancreatic Cancer Detection Data Published At ASCO 2024
04 Jun 2024 //
GLOBENEWSWIRE
Interpace Biosciences Q1 2024 Financials And Business Results
09 May 2024 //
GLOBENEWSWIRE
Interpace Announces Full-year and Fourth Quarter 2023 Financial Results
07 Mar 2024 //
GLOBENEWSWIRE
Interpace Announces Record Third Quarter 2023 Financial and Business Results
08 Nov 2023 //
GLOBENEWSWIRE
Interpace Biosciences Announces Record Second Quarter 2023 Financial Results
09 Aug 2023 //
GLOBENEWSWIRE
Flagship Biosciences snaps up Interpace’s Pharma Solutions
08 Sep 2022 //
FIERCEBIOTECH
Interpace Biosciences Completes Sale of Pharma Services Business to Flagship
31 Aug 2022 //
BIOSPACE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.